Form 4: Flora Growth Director's Stock Appreciation Rights Amended with Lower Exercise Price

Flora Growth Corp. director Harold Wolkin's Stock Appreciation Rights (SARs) were amended with shareholder approval, reducing the exercise price from $1.30 to $0.58 for 30,000 shares.

Summary

• Harold Wolkin, a Director of Flora Growth Corp. (FLGC), had his Stock Appreciation Rights (SARs) amended.
• The amendment, which received shareholder approval, lowered the exercise price of 30,000 SARs from $1.30 to $0.58.
• The original SARs were granted on December 15, 2024, and the amendment transaction date is June 30, 2025.
• The SARs remain exercisable from December 15, 2024, and expire on December 15, 2034.
• Following this transaction, Harold Wolkin directly beneficially owns 30,000 SARs.

Sentiment

Score: 6

Explanation: The amendment of SARs with shareholder approval for a director is a planned compensation adjustment. While a lower exercise price could be seen as slightly negative for shareholders due to potential dilution, the shareholder approval mitigates this, suggesting it's a considered move for talent retention/incentivization. Overall, it's a neutral to slightly positive signal regarding management alignment and retention.

Positives

• Shareholder approval for the SAR amendment indicates transparency and alignment with corporate governance practices.
• The lower exercise price for SARs may serve as an incentive for the director, potentially aiding in retention and motivation.

Negatives

• A reduction in the exercise price of Stock Appreciation Rights could be perceived as dilutive to existing shareholders if the SARs are exercised and new shares are issued at a lower effective price.
• The amendment might suggest a need to re-incentivize management, potentially due to underperformance or a decline in stock price since the original grant.

Future Outlook

NA

Industry Context

This transaction is a routine insider compensation adjustment. In the broader industry, companies often adjust equity compensation terms to align with market conditions, retain key talent, or reflect changes in company performance, especially if stock prices have declined since original grants.

Corporate Governance

Related Party Transactions

• The amendment of Stock Appreciation Rights (SARs) for Harold Wolkin, a director of Flora Growth Corp., constitutes a related party transaction as it involves compensation terms between the company and a member of its management.

Stakeholder Impact

• Shareholders: Potential for minor dilution if SARs are exercised at a lower price, but the shareholder approval suggests acceptance of this compensation adjustment.
• Management/Director: Harold Wolkin benefits from more favorable terms for his equity compensation, potentially increasing his incentive and alignment with the company's long-term performance.

Next Steps

• The Stock Appreciation Rights (SARs) will remain exercisable until their expiration date of December 15, 2034.

Key Dates

Keywords

Flora Growth Corp., FLGC, Harold Wolkin, SEC Form 4, Stock Appreciation Rights, SARs, Director Compensation, Equity Compensation, Insider Transaction, Shareholder Approval